跳至主要内容
临床试验/NCT03393065
NCT03393065Unknown不适用

Lung Ultrasound Guided Fluid Management Protocol for the Critically Ill Patient: a Randomized Study

Professor Adrian Covic1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2017年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
10
试验地点
1
主要终点
28 days survival

研究概览

简要总结

In the Intensive Care Unit (ICU) this bedside method of assessing lung congestion could be useful in a better management of the critically ill patients with a wide range of respiratory failure causes (Acute Respiratory Distress Syndrome, COPD, acute pulmonary edema, pneumonia etc.). Fluid management is a key issue in the ICU where patients are either hemodynamic unstable and/or mechanically ventilated. A randomized study is proposed where in the interventional arm the fluid management (volume replacement, diuretics, use of vasopressors) will be guided using the BLS as a sign of pulmonary congestion.

详细描述

Inclusion criteria

  • Age 18 or older admitted to the Intensive Care Unit

Exclusion criteria

  • Due to LUS measurement limitation: patients with known persistent pleurisy, pulmonary fibrosis or pneumectomy;
  • Unwillingness to participate in the study.

Active arm diuretic administration algorithm

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Results of the lung ultrasounds will not be made publicly available

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 or older admitted to the Intensive Care Unit

排除标准

  • known persistent pleurisy, pulmonary fibrosis or pneumectomy (due to lung ultrasonography limitations);
  • unwillingness to participate in the study

研究组 & 干预措施

intervention group pulmonary congestion

Experimental

in the intervention group pulmonary congestion, as assessed by the BLS will guide the diuretic and fluid management, with a target of below 15 BLS. Furthermore, in the active arm, in the patients who will require a renal replacement therapy (RRT), BLS will be used to further guide the dialysis fluid prescription.

干预措施: Fluid management guided by BLS (Other)

Control group

No Intervention

control group the fluid management will not be LUS guided

结局指标

主要结局

28 days survival

时间窗: 28 days

all-cause mortality

次要结局

  • Intensive care unit hospitalization(28 days)
  • Duration of hospitalization(28 days)
  • Days on mechanical ventilation(28 days)

研究者

发起方
Professor Adrian Covic
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Professor Adrian Covic

Clinical Professor

Grigore T. Popa University of Medicine and Pharmacy

研究点 (1)

Loading locations...

相似试验